Department of Medicine 5 – Haematology and Oncology

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV (2014) Hehlmann R, Müller MC, Lauseker M, Hanfstein B, Fabarius A, Schreiber A, Proetel U, et al. Journal article Nilotinib combined with interleukin-2 mediates antitumor and immunological effects in a B16 melanoma model (2014) Geisler K, Reischer A, Kroeger I, Jacobs B, Meinhardt K, Bauer R, Ryffel B, et al. Journal article Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies (2014) Kremer A, Van Der Meijden ED, Honders MW, Pont MJ, Goeman JJ, Falkenburg JHF, Griffioen M Journal article Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia (2014) Jitschin R, Hofmann AD, Bruns H, Gießl A, Bricks J, Berger J, Saul D, et al. Journal article Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study (2014) Rogler A, Hoja S, Giedl J, Ekici AB, Wach S, Taubert H, Goebell P, et al. Journal article Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib (2014) Hanfstein B, Lauseker M, Hehlmann R, Saussele S, Erben P, Dietz C, Fabarius A, et al. Journal article Sedation assessment in a mobile intensive care unit: a prospective pilot-study on the relation of clinical sedation scales and the bispectral index (2014) Prottengeier J, Moritz A, Heinrich S, Gall C, Schmidt J Journal article Autocrine impact of VEGF-A on uveal melanoma cells (2014) Koch KR, Refaian N, Hos D, Schlereth SL, Bosch JJ, Cursiefen C, Heindl LM Journal article Advances in cellular therapy: 7th international symposium on the clinical use of cellular products, March 14 and 15, 2013, Erlangen, Germany (2014) Aigner M, Bruns H, Gary R, Jitschin R, Kremer A, Mougiakakos D, Voelkl S, et al. Journal article Targeting high-grade B cell lymphoma with CD19-specific T cells (2014) Lehmann FM, Maurberger A, Feicht S, Helm F, Ladinig C, Kieback E, Uckert W, et al. Journal article